“Genital HIV-1 Shedding among Women Starting Second-Line Antiretroviral Therapy”

Funding: NIH/NIAID K23 AI069990                                                                              

PI: Graham

Time Period: 8/5/06 – 6/30/11

The goal of this study is to estimate the prevalence of drug-resistance HIV in the genital secretions of women failing first-line therapy in Kenya and to follow up the resuppression of genital HIV-1 shedding after initiation of second-line antiretroviral therapy.

Comments are closed.